Dr. Xian-Cheng Jiang (PhD) is a Distinguished Professor of State University of New York (SUNY). He is working at the Department of Cell Biology, SUNY Downstate Health Sciences University. His research focuses on lipid metabolism and  metabolic diseases, such as atherosclerosis, metabolic syndrome, obesity and liver steatosis, particularly how phospholipid metabolism influences plasma lipoprotein metabolism, cell membrane lipid composition and function, and the development of metabolic diseases.

• Chapter 1: Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.- Chapter 2: Cholesteryl Ester Transfer Protein and Lipid Metabolism and Cardiovascular Diseases.- Chapter 3: Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein in Lipid Metabolism and Cardiovascular Diseases.- Chapter 4: Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases.- Chapter 5: Circadian-Clock Regulation on Lipid Metabolism and Metabolic Diseases.- Chapter 6: ABC Transporters, Cholesterol Efflux and Implications for Cardiovascular Diseases.- Chapter 7: Apolipoprotein M: research progress and clinical perspective.- Chapter 8: Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.- Chapter 9: Proprotein Convertase Subtilisin/Kexin-type 9 and Lipid Metabolism.- Chapter 10: LDL and HDL Oxidative Modification and Atherosclerosis.- Chapter 11: Rare Diseases Related with Lipoprotein Metabolism.- Chapter 12: Preβ1 High Density Lipoprotein in Cardiovascular Diseases.- Chapter 13: CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.- Chapter 14: Mfsd2a, a physiologically important lysolipid transporter in brain and eye.

Dr. Xian-Cheng Jiang (PhD) is a Distinguished Professor of State University of New York (SUNY). He is working at the Department of Cell Biology, SUNY Downstate Health Sciences University. His research focuses on lipid metabolism and  metabolic diseases, such as atherosclerosis, metabolic syndrome, obesity and liver steatosis, particularly how phospholipid metabolism influences plasma lipoprotein metabolism, cell membrane lipid composition and function, and the development of metabolic diseases.

• Chapter 1: Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.- Chapter 2: Cholesteryl Ester Transfer Protein and Lipid Metabolism and Cardiovascular Diseases.- Chapter 3: Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein in Lipid Metabolism and Cardiovascular Diseases.- Chapter 4: Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases.- Chapter 5: Circadian-Clock Regulation on Lipid Metabolism and Metabolic Diseases.- Chapter 6: ABC Transporters, Cholesterol Efflux and Implications for Cardiovascular Diseases.- Chapter 7: Apolipoprotein M: research progress and clinical perspective.- Chapter 8: Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.- Chapter 9: Proprotein Convertase Subtilisin/Kexin-type 9 and Lipid Metabolism.- Chapter 10: LDL and HDL Oxidative Modification and Atherosclerosis.- Chapter 11: Rare Diseases Related with Lipoprotein Metabolism.- Chapter 12: Preβ1 High Density Lipoprotein in Cardiovascular Diseases.- Chapter 13: CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.- Chapter 14: Mfsd2a, a physiologically important lysolipid transporter in brain and eye.

Dr. Xian-Cheng Jiang (PhD) is a Distinguished Professor of State University of New York (SUNY). He is working at the Department of Cell Biology, SUNY Downstate Health Sciences University. His research focuses on lipid metabolism and  metabolic diseases, such as atherosclerosis, metabolic syndrome, obesity and liver steatosis, particularly how phospholipid metabolism influences plasma lipoprotein metabolism, cell membrane lipid composition and function, and the development of metabolic diseases.

• Chapter 1: Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.- Chapter 2: Cholesteryl Ester Transfer Protein and Lipid Metabolism and Cardiovascular Diseases.- Chapter 3: Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein in Lipid Metabolism and Cardiovascular Diseases.- Chapter 4: Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases.- Chapter 5: Circadian-Clock Regulation on Lipid Metabolism and Metabolic Diseases.- Chapter 6: ABC Transporters, Cholesterol Efflux and Implications for Cardiovascular Diseases.- Chapter 7: Apolipoprotein M: research progress and clinical perspective.- Chapter 8: Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.- Chapter 9: Proprotein Convertase Subtilisin/Kexin-type 9 and Lipid Metabolism.- Chapter 10: LDL and HDL Oxidative Modification and Atherosclerosis.- Chapter 11: Rare Diseases Related with Lipoprotein Metabolism.- Chapter 12: Preβ1 High Density Lipoprotein in Cardiovascular Diseases.- Chapter 13: CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.- Chapter 14: Mfsd2a, a physiologically important lysolipid transporter in brain and eye.